Fig. 7.
Effect of ANG-(1–7), the B2RA bradyzine, or ANG-(1–7) plus bradyzine on the NS-induced increase in NE (A) and NPY (B) overflow from 10- to 12-wk-old SHR mesenteric preparations. Drugs were administered as described in Fig. 4. Data are plotted as fold change from control (set as 1; NS in the absence of drugs) in the presence of ANG-(1–7) (0.01 μM), bradyzine (0.1 μM), or ANG-(1–7) plus bradyzine. **P < 0.01 and ***P < 0.001 compared with control.